Human CD36 deficiency is associated with elevation in low-density lipoprotein-cholesterol

American Journal of Medical Genetics

Volumn 93, Issue 4, 2000, Pages 299-304

  Yanai, Hidekatsu ^a   Chiba, Hitoshi ^a   Morimoto, Mie ^b   Abe, Keisuke ^a   Fujiwara, Hironobu ^a   Fuda, Hirotoshi ^a   Hui, Shu Ping ^a   Takahashi, Yukihiro ^a   Akita, Harukuni ^a   Jamieson, G A ^c   Kobayashi, Kunihiko ^a   Matsuno, Kazuhiko ^b  

^a HOKKAIDO UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c Cell Biology Department   (United States)

Author keywords

HDL; Monocyte; Mutation; Platelet

Indexed keywords

CD36 ANTIGEN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FLOW CYTOMETRY; GENETIC DISORDER; HUMAN; HYPERLIPIDEMIA; LIPID METABOLISM; MALE; MONOCYTE; PRIORITY JOURNAL; THROMBOCYTE;

ANTIGENS, CD36; GENE FREQUENCY; GENOTYPE; HUMANS; LIPIDS; LIPOPROTEINS, LDL; PHENOTYPE;

EID: 0034648493     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-8628(20000814)93:4<299::AID-AJMG9>3.0.CO;2-7     Document Type: Article

References (28)

1. Abumrad NA, El-Maghrabi MR, Amri E, Lopez E, Grimaldi PA. 1993. Cloning of rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation: homology with human CD36. J Biol Chem 268:17665-17668.
2. Aitman JA, Glazier AM, Wallace CA, Cooper LD, Norsworthy PJ, Wahid FN, Al-Majali KM, Trembling PM, Mann CJ, Shoulders CC, Graf D, St. Lezin E, Kurtz TW, Kren V, Pravenec M, Ibrahimi A, Abumrad NA, Stanton LW, Scott J. 1999. Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nat Genet 21:76-83.
3. Asch AS, Barnwell J, Silverstein RL, Nachman RL. 1987. A human 88-kD membrane glycoprotein (CD36) functions in vitro as a receptor for a cytoadherence ligand on Plasmodium falciparum-infected crythrocytes. J Clin Invest 79:1054-1061.
4. Asch AS, Liu I, Briccetti FM, Barnwell JW, Kwakye-Berko F, Dokun A, Goldberger J, Pernambuco M. 1991. Analysis of CD36 binding domain: ligand specificity controlled by dephosphorylation of an ectodomain. Science 262:1436-1440.
5. Calvo D, Gómez-Coronado D, Suárez Y, Lasunción MA, Vega MA. 1998. Human CD36 is a high affinity for the native lipoproteins HDL, LDL, VLDL. J Lipid Res 39:777-788.
6. a-negative platelet phenotype in African Americans in similar to that of Asians. Transfusion 36:331-334.
7. Endemann G, Stanton LW, Madden KS, Bryant CM, White RT, Protter AA. 1993. CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem 268:11811-11816.
8. Febbraio M, Abumrad NA, Hajjar DP, Sharma K, Cheng W, Pearce SFA, Silverstein RL. 1999. A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism. J Biol Chem 274:19055-19062.
9. Fernandez-Ruiz E, Armesilla AL, Sanchez-Madrid F, Vega MA. 1993. The gene encoding collagen type IV and thrombospondin receptor CD36 is located on chromosome 7q11,12. Genomics 17:759-761.
10. Friedewald WT, Levy RI, Fredrickson DS. 1972. Estimation of the concentration of low-density lipoprotein cholesterol on plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502.
11. Gotoda T, Lizuka Y, Kato N, Osuga J, Bihoreau MT, Murakami T, Yamori Y, Shimano H, Ishibashi S, Yamada N. 1999. Absence of Cd36 mutations in the original spontaneously hypertensive rats with insulin resistance. Nat Genet 22:226-228.
12. Greenwalt DE, Watt KWK. 1990. PAS IV, an integral membrane protein of mammary epithelial cells, is related to platelet and endothelial cell CD36 (GPIV). Biochemistry 29:7054-7059.
13. a, involved in the refractoriness of HLA-matched platelet transfusion. Vox Sang 57: 213-217.
14. Kashiwagi H, Tomiyama Y, Honda S, Kosugi S, Shiraga M, Nagao N, Sekiguchi S, Kanakura Y, Kurata Y, Matsuzawa Y. 1995. Molecular basis of CD36 deficiency. J Clin Invest 95:1040-1046.
15. Kashiwagi H, Tomiyama Y, Kosugi S, Shiraga M, Lipsky RH, Kanakura Y, Kurata Y, Matsuzawa Y. 1994. Identification of molecular defects in a subject with type 1 CD36 deficiency. Blood 83:3545-3552.
16. Kashiwagi H, Tomiyama Y, Nozaki S, Honda S, Kosugi S, Shiraga M, Nakagawa T, Nagao N, Kanakura Y, Kurata Y, Matsuzawa Y. 1996. A single nucleotide insertion in codon 317 of the CD36 gene leads to CD36 deficiency. Arterioscler Thromb Vasc Biol 16:1026-1032.
17. Knowles II DM, Tolidjian B, Marboe C, D'Agati V, Grimes M, Chess L. 1984. Monoclonal anti-human monocyte antibodies OKM1 and OKM5 possess distinctive tissue distribution including differential reactivity with vascular endothelium. J Immunol 132:2170-2173.
18. Lin M, Shieh SH, Yang TF. 1993. Frequency of platelet-specific antigens among Chinese in Taiwan. Transfusion 33:155-157.
19. Nagy L, Tontonoz P, Alvarez JGA, Evans RM. 1998. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARγ. Cell 93:229-240.
20. Nozaki S, Kashiwagi H, Yamashita S, Nakagawa T, Kostner B, Tomiyama Y, Nakata A, Ishigami M, Miyagawa J, Matsuzawa Y. 1995. Reduced uptake of oxidized low density lipoproteins in monocyte-derived macrophages from CD36-deficient subjects. J Clin Invest 96:1859-1865.
21. Reaven GM. 1988. Role of insulin resistance in human disease. Diabetes 37:1595-1607.
22. Santoso S, Kiefel V, Masri R. Mueller-Eckhardt C. 1993. Frequency of platelet-specific antigens among Indonesians. Transfusion 33:739-741.
23. Silverstein RL, Asch AS, Nachman RL. 1989. Glycoprotein IV mediated thrombospondin-dependent platelet-monocyte and platelet-U937 cell adhesion. J Clin Invest 84:546-552.
24. Tanaka T, Sohmiya K, Kawanura K. 1997. Is CD36 deficiency an etiology of hereditary hypertrophic cardiomyopathy? J Mol Cell Cardiol 29:121-127.
25. Tandon, NN, Lipsky RH, Burgess WH, Jamieson GA. 1989. Isolation and characterization of platelet glycoprotein IV (CD36). J Biol Chem 264: 7570-7575.
26. Tontonoz P, Nagy L, Alvarez JGA, Evans RM. 1998. PPARγ promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 93:241-252.
27. Yamamoto N, Akamatsu H, Sakuraba H, Yamazaki H, Tanoue K. 1994. Platelet glycoprotein IV (CD36) deficiency is associated with the absence (type I) or the presence (type II) of glycoprotein IV on monocytes. Blood 83:392-397.
28. Yanai H, Chiba H, Morimoto M, Jamieson GA, Matsuno K. 2000. Type I CD36 deficiency in human is not associated with insulin resistance syndrome. Thromb Haemost 83:786.